TY - JOUR
T1 - Involvement of δ2 opioid receptors in acute dependence on morphine in mice
AU - Miyamoto, Y.
AU - Portoghese, P. S.
AU - Takemori, A. E.
PY - 1993
Y1 - 1993
N2 - The effects that naltriben (NTB) and naltrindole 5'-isothiocyanate (5'- NTII) have on acute morphine dependence were investigated in mice. The degree of acute dependence was estimated by the ED50 value of s.c.-administered naloxone that was required to precipitate withdrawal jumping 4 hr after s.c. injection of 100 mg/kg of morphine sulfate (MS-100). Pretreatments with NTB (10 μmol/kg, s.c., 30 min before MS-100) and 5'-NTII (10 μmol/kg, s.c., 24 hr before MS-100) increased the ED50 values of naloxone compared to those of the respective saline-treated control mice. Although NTB itself (up to 10 μmol/kg, s.c.) did not precipitate jumping 4 hr after MS-100, small doses of NTB (1 and 2 μmol/kg, s.c.) administered 30 min before the challenge doses of naloxone increased substantially the ED50 value of naloxone. These results suggest that δ2 opioid receptors are involved in acute dependence on morphine in mice.
AB - The effects that naltriben (NTB) and naltrindole 5'-isothiocyanate (5'- NTII) have on acute morphine dependence were investigated in mice. The degree of acute dependence was estimated by the ED50 value of s.c.-administered naloxone that was required to precipitate withdrawal jumping 4 hr after s.c. injection of 100 mg/kg of morphine sulfate (MS-100). Pretreatments with NTB (10 μmol/kg, s.c., 30 min before MS-100) and 5'-NTII (10 μmol/kg, s.c., 24 hr before MS-100) increased the ED50 values of naloxone compared to those of the respective saline-treated control mice. Although NTB itself (up to 10 μmol/kg, s.c.) did not precipitate jumping 4 hr after MS-100, small doses of NTB (1 and 2 μmol/kg, s.c.) administered 30 min before the challenge doses of naloxone increased substantially the ED50 value of naloxone. These results suggest that δ2 opioid receptors are involved in acute dependence on morphine in mice.
UR - http://www.scopus.com/inward/record.url?scp=0027438972&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027438972&partnerID=8YFLogxK
M3 - Article
C2 - 8389861
AN - SCOPUS:0027438972
SN - 0022-3565
VL - 265
SP - 1325
EP - 1327
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 3
ER -